In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin
- 1 April 1987
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 6 (4) , 301-306
- https://doi.org/10.1016/0732-8893(87)90179-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acidJournal of Antimicrobial Chemotherapy, 1986
- In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteriaAntimicrobial Agents and Chemotherapy, 1985
- In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agentAntimicrobial Agents and Chemotherapy, 1984
- Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprimAntimicrobial Agents and Chemotherapy, 1983
- In vitro and in vivo antibacterial activity of AT-2266Antimicrobial Agents and Chemotherapy, 1983